Abiraterone Acetate Attenuates SARS-CoV-2 Replication by Interfering with the Structural Nucleocapsid Protein-Reference-Cited by-同舟云学术

Abiraterone Acetate Attenuates SARS-CoV-2 Replication by Interfering with the Structural Nucleocapsid Protein

Published:2022-05-13 Issue:5 Volume:30 Page:427-434
ISSN:1976-9148
Container-title:Biomolecules & Therapeutics
language:en
Short-container-title:Biomol Ther (Seoul)

Author:

Kim Jinsoo¹,Hwang Seok Young²,Kim Dongbum³,Kim Minyoung¹,Baek Kyeongbin¹,Kang Mijeong¹,An Seungchan²,Gong Junpyo²,Park Sangkyu⁴,Kandeel Mahmoud⁵⁶,Lee Younghee⁴,Noh Minsoo²,Kwon Hyung-Joo¹³

Affiliation:

1. Department of Microbiology, College of Medicine, Hallym University, Chuncheon 24252, Republic of Korea

2. College of Pharmacy, Natural Products Research Institute, Seoul National University, Seoul 08826, Republic of Korea

3. Institute of Medical Science, College of Medicine, Hallym University, Chuncheon 24252, Republic of Korea

4. Department of Biochemistry, College of Natural Sciences, Chungbuk National University, Cheongju 28644, Republic of Korea

5. Department of Biomedical Sciences, College of Veterinary Medicine, King Faisal University, Al-hofuf 31982, Saudi Arabia

6. Department of Pharmacology, Faculty of Veterinary Medicine, Kafrelshikh University, Kafrelshikh 33516, Egypt

Funder

National Research Foundation of Korea

Deanship of Scientific Research, King Faisal University

Publisher

The Korean Society of Applied Pharmacology

Subject

Drug Discovery,Pharmacology,Molecular Medicine,Biochemistry

Link

http://pdf.medrang.co.kr/BT2/2022/030/BT030-05-427.pdf

Reference38 articles.

1. Antiviral activity of digoxin and ouabain against SARS-CoV-2 infection and its implication for COVID-19

2. SARS-CoV-2 pandemic and research gaps: Understanding SARS-CoV-2 interaction with the ACE2 receptor and implications for therapy

3. Identification of Atovaquone, Ouabain and Mebendazole as FDA Approved Drugs Tar-geting SARS-CoV-2 (Version 4)

4. Computational protein–ligand docking and virtual drug screening with the AutoDock suite

5. COVID-19 among fit patients with CLL treated with venetoclax-based combinations

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of SARS-CoV-2 Mutations after Nirmatrelvir Treatment in a Lung Cancer Xenograft Mouse Model;Biomolecules & Therapeutics;2024-06-05

2. Antiandrogens as Therapies for COVID-19: A Systematic Review;Cancers;2024-01-10

3. In vitro and in vivo suppression of SARS‐CoV‐2 replication by a modified, short, cell‐penetrating peptide targeting the C‐terminal domain of the viral spike protein;Journal of Medical Virology;2023-03

4. Production of a Monoclonal Antibody to the Nucleocapsid Protein of SARS-CoV-2 and Its Application to ELISA-Based Detection Methods with Broad Specificity by Combined Use of Detector Antibodies;Viruses;2022-12-21

5. Differential effect of SARS-CoV-2 infection on stress granule formation in Vero and Calu-3 cells;Frontiers in Microbiology;2022-08-23